The current state of molecularly targeted drugs targeting HGF/Met. (Q53076447)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 December 2013

edit

Language	Label	Description	Also known as
English	The current state of molecularly targeted drugs targeting HGF/Met.	scientific article published on 25 December 2013

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24371262

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/24371262

title

The current state of molecularly targeted drugs targeting HGF/Met. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24371262

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/24371262

author name string

Seiji Yano

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24371262

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/24371262

Takayuki Nakagawa

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24371262

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/24371262

publication date

25 December 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24371262

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/24371262

published in

Japanese Journal of Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24371262

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/24371262

volume

44

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24371262

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/24371262

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24371262

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/24371262

page(s)

9-12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24371262

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/24371262

cites work

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2009.11.022

Identifiers

DOI

10.1093/JJCO/HYT188

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24371262

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/24371262

PubMed publication ID

24371262

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24371262

retrieved

11 May 2018

reference URL

http://europepmc.org/abstract/MED/24371262

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53076447&oldid=1647784070"